Title:
ピリド［３，４−ｄ］ピリミジン誘導体及びその薬学的に許容される塩
Document Type and Number:
Japanese Patent JP6400196
Kind Code:
B2
Abstract:
The purpose of the present invention is to provide a compound having an excellent CDK4/6 inhibiting activity. The present invention is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof.
Inventors:
Tsuyoshi Mizuno
Tomoda Shimada
Unoki
Ebisawa Masaru
Susumu Takeuchi
Kunio Minamizono
Kosuke Sasaki
Takuya Yokosaka
Junji Igarashi
Akinobu Maruyama
High Hiro Hiro
Horie Kyohei
Sakai Yuri
Tomoda Shimada
Unoki
Ebisawa Masaru
Susumu Takeuchi
Kunio Minamizono
Kosuke Sasaki
Takuya Yokosaka
Junji Igarashi
Akinobu Maruyama
High Hiro Hiro
Horie Kyohei
Sakai Yuri
Application Number:
JP2017521910A
Publication Date:
October 03, 2018
Filing Date:
May 27, 2016
Export Citation:
Assignee:
Teijin Pharma Limited
International Classes:
C07D471/04; A61K31/519; A61K31/5377; A61K31/541; A61K31/55; A61K31/551; A61K31/553; A61P9/10; A61P11/00; A61P19/02; A61P29/00; A61P35/00; A61P43/00; C07D519/00
Domestic Patent References:
| JP2005519909A | ||||
| JP2007530425A |
Foreign References:
| WO2014037750A1 |
Other References:
Organic & Biomolecular Chemistry,2015年 1月21日,13,893-904
Attorney, Agent or Firm:
Atsushi Aoki
Shinji Mitsuhashi
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Shinji Mitsuhashi
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei